Document is current
Any future updates will be listed below
-
Authors
Lameirinhas, Ana
Torres-Ruiz, Sandra
Garrido-Cano, Iris
Hernando, Cristina
Martínez, María Teresa
Rovira, Ana
Albanell, Joan
Zazo, Sandra
Rojo, Federico
Bermejo, Begoña
Lluch, Ana
Cejalvo, Juan Miguel
Tormo, Eduardo
Eroles, Pilar
-
Funding
Funding for this research was provided by:
Asociación Española Contra el Cancer (PRDVA19016LAME)
Conselleria d’Educació, Investigació, Cultura i Esport, Generalitat Valenciana (ACIF/2019/119)
European Union-Next generation EU (Margarita Salas postdoctoral grant)
Spanish Government and cofinanced by FEDER Funds (PI21/00002, PI21/00142, PI21/01351)
Spanish Government CIBERONC (CB16/12/00241, CB16/12/00481)
Sociedad Española de Oncología Médica (Río Hortega-SEOM)
- License Information
-
More Information
Article History
Received: 13 January 2025
Accepted: 11 March 2025
First Online: 25 March 2025
Declarations
:
: The study was approved by the INCLIVA institutional review board (2018/077) and followed the ethical guidelines (Declaration of Helsinki). All participants provided written informed consent to take part in the study.
: The authors have read the journal policies and confirm the submission of this manuscript in accordance with those policies.
: The authors declare no competing interests.
